Biological variability has long been a major bottleneck in life science research and drug development, leading to irreproducible results and extended timelines.
This article provides a comprehensive framework for benchmarking machine learning (ML) methods within Design-Build-Test-Learn (DBTL) cycles, tailored for researchers and professionals in drug development.
This article provides a comprehensive guide for researchers and drug development professionals on leveraging machine learning, specifically Gradient Boosting and Random Forest, within Design-Build-Test-Learn (DBTL) cycles under data-scarce conditions.
This article provides a comprehensive guide for researchers and drug development professionals on integrating the exploration-exploitation dilemma from machine learning into Design-Build-Test-Learn (DBTL) cycles.
This article provides a strategic framework for researchers and drug development professionals to maximize the efficiency and success of Design-Build-Test-Learn (DBTL) cycles in data-scarce environments.
This article explores the transformative role of machine learning-based Automated Recommendation Tools (ART) in the Design-Build-Test-Learn (DBTL) cycle for researchers and drug development professionals.
This article explores the transformative impact of knowledge-driven Design-Build-Test-Learn (DBTL) cycles in synthetic biology and biopharmaceutical development.
This article explores the transformative integration of AI agents into closed-loop Design-Build-Test-Learn (DBTL) platforms for drug discovery.
This article explores the strategic integration of Design of Experiments (DoE) to efficiently reduce the combinatorial library size in Design-Build-Test-Learn (DBTL) cycles for biomedical research and drug development.
This article provides a comprehensive exploration of combinatorial pathway optimization through the lens of the Design-Build-Test-Learn (DBTL) cycle, a foundational framework in synthetic biology and precision medicine.